Jade Biosciences is a clinical-stage biotechnology company focused on developing best-in-class therapies that address critical unmet needs in autoimmune diseases. Jade’s lead candidate, JADE101, targets the cytokine APRIL, and is currently being evaluated in a Phase 1 clinical trial for the treatment of immunoglobulin A nephropathy. Jade’s pipeline also includes JADE201, an afucosylated anti-BAFF-R monoclonal antibody, as well as JADE301, an undisclosed antibody candidate, both currently in preclinical development. Jade was launched based on assets licensed from Paragon Therapeutics, an antibody discovery engine founded by Fairmount. For more information, visit JadeBiosciences.com and follow the Company on LinkedIn. We are seeking a dynamic CMC Regulatory Affairs leader to join our Regulatory team. The Director, CMC Regulatory Affairs is a newly created position reporting to the Executive Director, CMC Regulatory Affairs. This role provides strategic and operational leadership for global CMC regulatory activities supporting the development, registration, and lifecycle management of biologic and combination products. Key responsibilities include leading global CMC regulatory strategy, preparing and managing regulatory submissions, briefing documents, and health authority meeting packages, supporting health authority interactions, and providing regulatory guidance on manufacturing processes, analytical methods, specifications, stability, comparability, and post-approval changes. The ideal candidate will bring strong scientific and regulatory expertise, sound judgment, and the ability to interpret complex data and collaborate effectively with internal and external cross-functional stakeholders, including CMC, Quality Assurance, Supply Chain, Clinical, and external partners. This is a fully remote role with occasional travel required.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Director